Sanjal H. Desai

Also affiliated with Mayo Clinic, Mayo Clinic in Arizona, University of Minnesota Medical Center, Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study”.

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1888379

N/A

0.286DataRank · unranked

4 citations

Clifton C. Mo, Erika M. Gaglione, Constance M. Yuan, Maryalice Stetler‐Stevenson, Xin Tian +20 more

Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1772477

N/A

0DataRank · unranked

27 citations

Clare Sun, Sanjal H. Desai, Inhye E. Ahn, Xin Tian, Pia Nierman +6 more

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma

Hematological Oncology(2022)10.1002/hon.3098

N/A

0DataRank · unranked

7 citations

Raphael Mwangi, Alexandra N. Smith, Matthew J. Maurer, Umar Farooq, Rebecca L. King +9 more